BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 7050853)

  • 21. [The antimycotica disc elution test: a new quantitative antimycotica test for yeasts (author's transl)].
    Werk R; Haass R
    Immun Infekt; 1982 May; 10(3):110-4. PubMed ID: 7047363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanisl of action of clotrimazole. 2. Effects on the cell membrane of Candida albicans].
    Yamaguchi H; Iwata K
    Nihon Saikingaku Zasshi; 1974 Mar; 29(2):379-85. PubMed ID: 4603678
    [No Abstract]   [Full Text] [Related]  

  • 23. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
    La Regina G; D'Auria FD; Tafi A; Piscitelli F; Olla S; Caporuscio F; Nencioni L; Cirilli R; La Torre F; De Melo NR; Kelly SL; Lamb DC; Artico M; Botta M; Palamara AT; Silvestri R
    J Med Chem; 2008 Jul; 51(13):3841-55. PubMed ID: 18529046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans.
    Georgopapadakou NH; Dix BA; Smith SA; Freudenberger J; Funke PT
    Antimicrob Agents Chemother; 1987 Jan; 31(1):46-51. PubMed ID: 3551826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
    Kurnatowski P; Makieło L; Horwatt-Bozyczko E
    Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological effects of econazole nitrate on yeast cells.
    Kern R; Zimmermann FK
    Mykosen Suppl; 1978; 1():339-45. PubMed ID: 400882
    [No Abstract]   [Full Text] [Related]  

  • 27. Ultrastructural findings of Candida albicans blastoconidia submitted to the action of fenticonazole.
    Costa A; Veronese M; Ruggeri P; Valenti A
    Arzneimittelforschung; 1989 Feb; 39(2):230-3. PubMed ID: 2659001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Odds FC; Cockayne A; Hayward J; Abbott AB
    J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of strains of Candida albicans to jaritin, haloprogin, clotrimazole and miconazole.
    Langsadl L; Jedlickova Z
    Postgrad Med J; 1979 Sep; 55(647):695-6. PubMed ID: 392487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of imidazole derivatives on various numbers of microbes to determine microbial sensitivity].
    Raab W; Högl F
    Z Hautkr; 1980 Sep; 55(17):1116-22. PubMed ID: 7008401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of human T-lymphocyte plasma membrane Ca2+ permeability by imidazole antimycotics.
    Hornstein EH; Vassilopoulos D; Thomas DE; Friedman FK; Tsokos GC
    Immunopharmacol Immunotoxicol; 1996 May; 18(2):237-45. PubMed ID: 8771369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro].
    Abe S; Tansho S; Perera PD; Hiratani T; Nishiyama Y; Uchida K; Yamaguchi H
    Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):103-7. PubMed ID: 9580036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorination-induced enhancement of biological activities in imidazole antimycotics. A possible explanation to the molecular mechanism for their antimycotic activities.
    Kawai K; Shiojiri H; Watanabe R; Nozawa Y
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):255-65. PubMed ID: 6878866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interaction of [3H]miconazole with Candida albicans.
    Cope JE
    Sabouraudia; 1980 Sep; 18(3):211-28. PubMed ID: 7001652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A replica plating technique for in vitro study of susceptibility of Candida albicans to miconazole, econazole and ketoconazole: some data for standardization.
    Sanchez-Sousa A; Gomez-Criado C; Jimenez ML; Fernandez-Jorge A; Baquero F
    Ann Inst Pasteur Microbiol (1985); 1985; 136A(3):371-80. PubMed ID: 3901880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum.
    Tzatzarakis MN; Tsatsakis AM; Charvalos E; Vakalounakis D
    J Environ Sci Health B; 2001 May; 36(3):331-40. PubMed ID: 11411855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imidazole-induced morphological abnormalities of mitochondria of Candida albicans.
    Yang HC; Taguchi H; Nishimura K; Miyaji M
    Mycoses; 1998 Dec; 41(11-12):481-6. PubMed ID: 9919891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of action of the antimycotic agent econazole].
    Kern R; Zimmermann K
    Mykosen; 1977 Apr; 20(4):133-46. PubMed ID: 325404
    [No Abstract]   [Full Text] [Related]  

  • 39. Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study.
    Cassone A; Mason RE; Kerridge D
    Sabouraudia; 1981 Jun; 19(2):97-110. PubMed ID: 7020114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disk diffusion susceptibility testing of dermatophytes with imidazoles.
    Venugopal PV; Venugopal TV
    Indian J Pathol Microbiol; 1995 Oct; 38(4):369-74. PubMed ID: 9726146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.